{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T17:53:57Z","timestamp":1761155637347,"version":"3.40.4"},"reference-count":205,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[1988,12,1]],"date-time":"1988-12-01T00:00:00Z","timestamp":596937600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medical Toxicology"],"published-print":{"date-parts":[[1988,12]]},"DOI":"10.1007\/bf03259895","type":"journal-article","created":{"date-parts":[[2012,11,29]],"date-time":"2012-11-29T10:33:52Z","timestamp":1354185232000},"page":"430-448","source":"Crossref","is-referenced-by-count":28,"title":["Haematological Adverse Effects of Histamine H2-Receptor Antagonists"],"prefix":"10.1007","volume":"3","author":[{"given":"Jean-Pierre","family":"Aymard","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernadette","family":"Aymard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick","family":"Netter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernard","family":"Bannwarth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philippe","family":"Trechot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fran\u00e7ois","family":"Streiff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,11,27]]},"reference":[{"key":"BF03259895_CR1","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1111\/j.1365-2125.1987.tb03185.x","volume":"24","author":"PA Abraham","year":"1987","unstructured":"Abraham PA, Opsahl JA, Halstenson CE, Chremos AN, Matzke GR, et al. The effect of famotidine on renal function in patients with renal insufficiency. British Journal of Clinical Pharmacology 24: 385\u2013389, 1987","journal-title":"British Journal of Clinical Pharmacology"},{"key":"BF03259895_CR2","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/BF02004513","volume":"41","author":"M Aglietta","year":"1985","unstructured":"Aglietta M, Stacchini A, Sanavio F, Piacibello W. H2-receptor antagonists and human granulopoiesis. Experientia 41: 375\u2013376, 1985","journal-title":"Experientia"},{"key":"BF03259895_CR3","first-page":"251","volume":"7","author":"H Albin","year":"1983","unstructured":"Albin H, Couzigou P, Vincon G, Pehourcq F, Fleury B, et al. Pharmacocin\/\u2019etique de la cimetidine chez le cirrhotique ascitique. Gastroenterologie Clinique et Biologique 7: 251\u2013255, 1983","journal-title":"Gastroenterologie Clinique et Biologique"},{"key":"BF03259895_CR4","doi-asserted-by":"crossref","first-page":"992","DOI":"10.7326\/0003-4819-90-6-992","volume":"90","author":"FH Al-Kawas","year":"1979","unstructured":"Al-Kawas FH, Lenes BA, Sacher RA. Cimetidine and agranulocytosis. Annals of Internal Medicine 90: 992\u2013993, 1979","journal-title":"Annals of Internal Medicine"},{"key":"BF03259895_CR5","first-page":"396","volume":"109","author":"JI Allen","year":"1987","unstructured":"Allen JI, Syropoulos HJ, Grant B, Eagon JC, Kay NE. Cimetidine modulates natural killer cell function of patients with chronic lymphocytic leukemia. Journal of Laboratory and Clinical Medicine 109: 396\u2013401, 1987","journal-title":"Journal of Laboratory and Clinical Medicine"},{"key":"BF03259895_CR6","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1177\/096032718700600609","volume":"6","author":"RJ Amos","year":"1987","unstructured":"Amos RJ, Kirk B, Amess JAL, Jones AL, Hinds CJ. Bone marrow hypoplasia during intensive care: bone marrow culture studies implicating ranitidine in the suppression of haemopoiesis. Human Toxicology 6: 503\u2013506, 1987","journal-title":"Human Toxicology"},{"key":"BF03259895_CR7","first-page":"202","volume":"36","author":"JP Aymard","year":"1981","unstructured":"Aymard JP, Balaud A, Netter P, Witz F, Colomb JN, et al. Hypoplasie m\u00e9dullaire avec pancytop\u00e9nie sanguine associ\u00e9e \u00e0 la pris\u00e9 de cimetidine. Th\u00e9rapie 36: 202\u2013203, 1981","journal-title":"Th\u00e9rapie"},{"key":"BF03259895_CR8","first-page":"855","volume":"30","author":"JP Aymard","year":"1982","unstructured":"Aymard JP, Herbeuval M, Herbeuval R, Witz, F, Lederlin P, et al. Action de la cimetidine sur les cellules souches de la granulopoi\u00e8se humaine (CFU-C): \u00e9tude in vitro sur 31 patients. Pathologie et Biologie 30: 855\u2013857, 1982","journal-title":"Pathologie et Biologie"},{"key":"BF03259895_CR9","first-page":"378","volume":"72","author":"A Bacigalupo","year":"1987","unstructured":"Bacigalupo A, Van Lint MT, Peralvo J, Piaggio G, Figari O, et al. Ranitidine and hematologic recovery in aplastic anemia. Haematologica (Pavia) 72: 378\u2013379, 1987","journal-title":"Haematologica (Pavia)"},{"key":"BF03259895_CR10","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1056\/NEJM198311033091801","volume":"309","author":"GC Bagby","year":"1983","unstructured":"Bagby GC, Lawrence HJ, Neerhout RC. T-Lymphocyte-mediated granulopoietic failure: in vitro identification of prednisone-responsive patients. New England Journal of Medicine 309: 1073\u20131078, 1983","journal-title":"New England Journal of Medicine"},{"key":"BF03259895_CR11","first-page":"381","volume":"7","author":"J Belaiche","year":"1983","unstructured":"Belaiche J, Zittoun J, Marquet J, Nurit Y, Yvart J. Effet de la ranitidine sur la s\u00e9cr\u00e9tion de facteur intrins\u00e8que gastrique et sur l\u2019absorption de la vitamine B12. Gastroenterologie Clinique et Biologique 7: 381\u2013384, 1983","journal-title":"Gastroenterologie Clinique et Biologique"},{"key":"BF03259895_CR12","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1001\/archinte.1986.00360240039006","volume":"146","author":"WR Bell","year":"1986","unstructured":"Bell WR, Anderson KC, Noe DA, Silver BA. Reduction in the plasma clearance rate of warfarin induced by cimetidine. Archives of Internal Medicine 146: 2325\u20132328, 1986","journal-title":"Archives of Internal Medicine"},{"issue":"l","key":"BF03259895_CR13","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1159\/000199264","volume":"32","author":"G Bianchi Porro","year":"1985","unstructured":"Bianchi Porro G. Famotidine in the treatment of gastric and duodenal ulceration: overview of clinical experience. Digestion 32 (Suppl.l): 62\u201369, 1985","journal-title":"Digestion"},{"key":"BF03259895_CR14","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/0016-5085(78)90764-3","volume":"74","author":"HJ Binder","year":"1978","unstructured":"Binder HJ, Donaldson RM. Effect of cimetidine on intrinsic factor and pepsin secretion in man. Gastroenterology 74: 371\u2013375, 1978","journal-title":"Gastroenterology"},{"key":"BF03259895_CR15","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/236385a0","volume":"236","author":"JW Black","year":"1972","unstructured":"Black JW, Duncan WAM, Durant CJ, Ganellin CR, Parsons EM. Definition and antagonism of histamine H2-receptors. Nature 236: 385\u2013390, 1972","journal-title":"Nature"},{"key":"BF03259895_CR16","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1097\/00004836-198103000-00017","volume":"3","author":"HC Bodenheimer","year":"1981","unstructured":"Bodenheimer HC, Thayer WR. Hemochromatosis associated with chronic cimetidine therapy? Journal of Clinical Gastroenterology 3: 83\u201385, 1981","journal-title":"Journal of Clinical Gastroenterology"},{"key":"BF03259895_CR17","doi-asserted-by":"crossref","first-page":"896","DOI":"10.7326\/0003-4819-104-6-896_2","volume":"104","author":"LO Brenner","year":"1986","unstructured":"Brenner LO. Agranulocytosis and ranitidine. Annals of Internal Medicine 104: 896\u2013897, 1986","journal-title":"Annals of Internal Medicine"},{"key":"BF03259895_CR18","first-page":"355","volume":"7","author":"JF Bretagne","year":"1983","unstructured":"Bretagne JF, Reymann JM, Tassou JJ, Alain H, Gosselin A, et al. Pharmacocin\u00e9tique de la ranitidine par voie intraveineuse et son effet sur la s\u00e9cr\u00e9tion acide stimul\u00e9e par la pentagastrine chez le cirrhotique. Gastroenterologie Clinique et Biologique 7: 355\u2013361, 1983","journal-title":"Gastroenterologie Clinique et Biologique"},{"key":"BF03259895_CR19","first-page":"177","volume-title":"Cimetidine: Proceedings of the 2nd International Symposium on Histamine H2-Receptor Antagonists","author":"WL Burland","year":"1977","unstructured":"Burland WL, Mills JG, Sharpe PC, Horton MA, Mollin DL. The effect of cimetidine on intrinsic factor secretion. In Burland WL & Simkins M (Eds) Cimetidine: Proceedings of the 2nd International Symposium on Histamine H2-Receptor Antagonists, pp. 177\u2013183, Excerpta Medica, Amsterdam. 1977"},{"key":"BF03259895_CR20","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/S0140-6736(75)90448-1","volume":"2","author":"WL Burland","year":"1975","unstructured":"Burland WL, Sharpe PC, Colin-Jones DG, Turnbull PRG, Bowskill P. Reversal of metiamide-induced agranulocytosis during treatment with cimetidine. Lancet 2: 1085, 1975","journal-title":"Lancet"},{"key":"BF03259895_CR21","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1016\/S0140-6736(76)91990-5","volume":"2","author":"JW Byron","year":"1976","unstructured":"Byron JW. Bone-marrow toxicity of metiamide. Lancet 2: 1350, 1976","journal-title":"Lancet"},{"key":"BF03259895_CR22","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/BF01969974","volume":"7","author":"JW Byron","year":"1977","unstructured":"Byron JW. Mechanism for histamine H2-receptor induced cell-cycle changes in the bone marrow stem cell. Agents and Actions 7: 209\u2013213, 1977","journal-title":"Agents and Actions"},{"key":"BF03259895_CR23","first-page":"256","volume":"8","author":"JW Byron","year":"1980","unstructured":"Byron JW. Pharmacodynamic basis for the interaction of cimetidine with the bone marrow stem cells (CFU-S). Experimental Hematology 8: 256\u2013263, 1980","journal-title":"Experimental Hematology"},{"key":"BF03259895_CR24","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1097\/00005373-198207000-00010","volume":"22","author":"HH Caffee","year":"1982","unstructured":"Caffee HH, Bingham HG. Leukopenia and silver sulfadiazine. Journal of Trauma 22: 586\u2013587, 1982","journal-title":"Journal of Trauma"},{"issue":"136","key":"BF03259895_CR25","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3109\/00365528709094480","volume":"22","author":"JT Callaghan","year":"1987","unstructured":"Callaghan JT, Bergstrom RF, Rubin, A, Chernish S, Crabtree R, et al. A pharmacokinetic profile of nizatidine in man. Scandinavian Journal of Gastroenterology 22 (Suppl. 136): 9\u201317, 1987","journal-title":"Scandinavian Journal of Gastroenterology"},{"key":"BF03259895_CR26","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/j.1476-5381.1982.tb08786.x","volume":"75","author":"MC Calzado","year":"1982","unstructured":"Calzado MC, Garcia-Castellano JM, Manzanares RM, Martinez F, Prieto B, et al. Effects of cimetidine on haematopoiesis in vitro. British Journal of Pharmacology 75: 301\u2013303, 1982","journal-title":"British Journal of Pharmacology"},{"key":"BF03259895_CR27","doi-asserted-by":"crossref","first-page":"197","DOI":"10.2165\/00003495-198632030-00001","volume":"32","author":"DM Campoli-Richards","year":"1986","unstructured":"Campoli-Richards DM, Clissold SP. Famotidine: pharmacodynamic and pharmacokinetic properties and a preliminary review of its therapeutic use in peptic ulcer disease and Zollinger-Ellison syndrome. Drugs 32: 197\u2013221, 1986","journal-title":"Drugs"},{"key":"BF03259895_CR28","doi-asserted-by":"crossref","first-page":"57","DOI":"10.7326\/0003-4819-93-1-57","volume":"93","author":"HW Carloss","year":"1980","unstructured":"Carloss HW, Tavassoli M, McMillan R. Cimetidine-induced granulocytopenia. Annals of Internal Medicine 93: 57\u201358, 1980","journal-title":"Annals of Internal Medicine"},{"key":"BF03259895_CR29","first-page":"92","volume":"73","author":"KL Chandrasekhara","year":"1981","unstructured":"Chandrasekhara KL, Iyer SK, Macchia RJ. Leucopenia and thrombocytopenia with cimetidine. Journal of the National Medical Association 73: 92\u201398, 1981","journal-title":"Journal of the National Medical Association"},{"key":"BF03259895_CR30","doi-asserted-by":"crossref","first-page":"580","DOI":"10.7326\/0003-4819-91-4-580","volume":"91","author":"HK Chang","year":"1979","unstructured":"Chang HK, Morrison SL. Bone-marrow suppression associated with cimetidine. Annals of Internal Medicine 91: 580, 1979","journal-title":"Annals of Internal Medicine"},{"key":"BF03259895_CR31","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/S0022-5347(25)00220-4","volume":"241","author":"MS Ching","year":"1987","unstructured":"Ching MS, Mihaly GW, Morgan DJ, Date NM, Hardy KJ, et al. Low clearance of cimetidine across the human placenta. Journal of Pharmacology and Experimental Therapeutics 241: 1006\u20131009, 1987","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"BF03259895_CR32","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/j.1365-2125.1986.tb05190.x","volume":"21","author":"IA Choonara","year":"1986","unstructured":"Choonara IA, Cholerton S, Haynes BP, Breckenridge AM, Park BK. Interaction between the R enantiomer of warfarin and cimetidine. British Journal of Clinical Pharmacology 21: 85P-86P, 1986","journal-title":"British Journal of Clinical Pharmacology"},{"issue":"136","key":"BF03259895_CR33","doi-asserted-by":"crossref","first-page":"29","DOI":"10.3109\/00365528709094483","volume":"22","author":"ML Cloud","year":"1987","unstructured":"Cloud ML, Safety of nizatidine in clinical trials conducted in the USA and Europe. Scandinavian Journal of Gastroenterology 22 (Suppl. 136): 29\u201336, 1987","journal-title":"Scandinavian Journal of Gastroenterology"},{"key":"BF03259895_CR34","first-page":"253","volume":"54","author":"DG Colin-Jones","year":"1985","unstructured":"Colin-Jones DG, Langman MJS, Lawson DH, Vessey MP. Postmarketing surveillance of the safety of cimetidine: twelve-month morbidity report. Quarterly Journal of Medicine 54: 253\u2013268, 1985","journal-title":"Quarterly Journal of Medicine"},{"key":"BF03259895_CR35","first-page":"257","volume":"132","author":"MJ Collen","year":"1980","unstructured":"Collen MJ. Cimetidine-associated thrombocytopenia and leukopenia. Western Journal of Medicine 132: 257\u2013258, 1980","journal-title":"Western Journal of Medicine"},{"key":"BF03259895_CR36","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1136\/bmj.1.6115.753-a","volume":"1","author":"CL Corbett","year":"1978","unstructured":"Corbett CL, Holdsworth CD. Fever, abdominal pain, and leucopenia during treatment with cimetidine. British Medical Journal 1: 753\u2013754, 1978","journal-title":"British Medical Journal"},{"key":"BF03259895_CR37","doi-asserted-by":"crossref","first-page":"250","DOI":"10.5694\/j.1326-5377.1981.tb100940.x","volume":"2","author":"RM Crapper","year":"1981","unstructured":"Crapper RM. Fatal agranulocytosis attributable to cimetidine. Medical Journal of Australia 2: 250\u2013251, 1981","journal-title":"Medical Journal of Australia"},{"key":"BF03259895_CR38","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/S0140-6736(77)90973-4","volume":"2","author":"ER Craven","year":"1977","unstructured":"Craven ER, Whittington JM. Agranulocytosis four months after cimetidine therapy. Lancet 2: 294\u2013295, 1977","journal-title":"Lancet"},{"key":"BF03259895_CR39","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1055\/s-2008-1070532","volume":"106","author":"HG Dammann","year":"1981","unstructured":"Dammann HG, Dorner M, Greten H. Granulozytopenie bei Behandlung mit Cimetidin. Deutsche Medizinische Wochenschrift 106: 1276, 1981","journal-title":"Deutsche Medizinische Wochenschrift"},{"key":"BF03259895_CR40","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1056\/NEJM198201073060106","volume":"306","author":"M Danilewitz","year":"1982","unstructured":"Danilewitz M, Ou Tim L, Hirschowilz B. Ranitidine suppression of gastric hypersecretion resistant to cimetidine. New England Journal of Medicine 306: 20\u201322, 1982","journal-title":"New England Journal of Medicine"},{"key":"BF03259895_CR41","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1001\/jama.1980.03300450026015","volume":"243","author":"TG Davis","year":"1980","unstructured":"Davis TG, Pickett DL, Schlosser JH. Evaluation of a worldwide spontaneous reporting system with cimetidine. Journal of the American Medical Association 243: 1912\u20131914, 1980","journal-title":"Journal of the American Medical Association"},{"key":"BF03259895_CR42","doi-asserted-by":"crossref","first-page":"274","DOI":"10.7326\/0003-4819-90-2-274_1","volume":"90","author":"C Galocsy De","year":"1979","unstructured":"De Galocsy C, Van Ypersele de Strihou C. Pancytopenia with cimetidine. Annals of Internal Medicine 90: 274, 1979","journal-title":"Annals of Internal Medicine"},{"key":"BF03259895_CR43","first-page":"2440","volume":"10","author":"J Denis","year":"1981","unstructured":"Denis J, Thierman-Duffaud D, Opolon P, Levy VG. Thrombop\u00e9nie induite par la cim\u00e9tidine. Nouvelle Presse M\u00e9dicale 10: 2440, 1981","journal-title":"Nouvelle Presse M\u00e9dicale"},{"key":"BF03259895_CR44","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/clpt.1984.40","volume":"35","author":"PV Desmond","year":"1984","unstructured":"Desmond PV, Mashford ML, Harman PJ, Morphett BJ, Breen KJ, et al. Decreased oral warfarin clearance after ranitidine and cimetidine. Clinical Pharmacology and Therapeutics 35: 338\u2013341, 1984","journal-title":"Clinical Pharmacology and Therapeutics"},{"key":"BF03259895_CR45","first-page":"537","volume":"1","author":"S Devanesen","year":"1981","unstructured":"Devanesen S. Prolongation of prothrombin time with cimetidine. Medical Journal of Australia 1: 537, 1981","journal-title":"Medical Journal of Australia"},{"key":"BF03259895_CR46","first-page":"81","volume":"18","author":"W D\u00f6lle","year":"1980","unstructured":"D\u00f6lle W, Sewing KF. Agranulocytosis after cimetidine after agranulocytosis induced by carbimazole in a woman with cirrhosis of the liver, hypersplenism and hyperthyroidism. Zeitschrift f\u00fcr Gastroenterologie 18: 81\u201382, 1980","journal-title":"Zeitschrift f\u00fcr Gastroenterologie"},{"key":"BF03259895_CR47","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1002\/j.1552-4604.1984.tb02788.x","volume":"24","author":"KH Donn","year":"1984","unstructured":"Donn KH, Powell JR, Rogers JF, Plachetka JR. Lack of effect of histamine H2-receptor antagonists on indocyanine green disposition measured by two methods. Journal of Clinical Pharmacology 24: 360\u2013370, 1984","journal-title":"Journal of Clinical Pharmacology"},{"key":"BF03259895_CR48","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1007\/BF01314472","volume":"24","author":"F Druart","year":"1979","unstructured":"Druart F, Frocrain C, Metois P, Martin J, Matuchansky C. Association of cimetidine and bone-marrow suppression in man. Digestive Diseases and Sciences 24: 730\u2013731, 1979","journal-title":"Digestive Diseases and Sciences"},{"key":"BF03259895_CR49","first-page":"523","volume":"9","author":"JL Dubost","year":"1980","unstructured":"Dubost JL, Chevallier H, Sultan R, Fallouh H. Neutropenie chez un malade trait\u00e9 par la cim\u00e9tidine. M\u00e9decine et Chirurgie Digestive 9: 523\u2013524, 1980","journal-title":"M\u00e9decine et Chirurgie Digestive"},{"key":"BF03259895_CR50","doi-asserted-by":"crossref","first-page":"280","DOI":"10.7326\/0003-4819-94-2-280_2","volume":"94","author":"FV Elizaga","year":"1981","unstructured":"Elizaga FV, Jim RTS, Lam CBC, Berman SJ. Hematologic effects of cimetidine. Annals of Internal Medicine 94: 280, 1981","journal-title":"Annals of Internal Medicine"},{"key":"BF03259895_CR51","doi-asserted-by":"crossref","first-page":"620","DOI":"10.7326\/0003-4819-97-4-620_1","volume":"97","author":"S Eridani","year":"1982","unstructured":"Eridani S, Johnston IDA, Villa S. Cimetidine and granulopoiesis. Annals of Internal Medicine 97: 620, 1982","journal-title":"Annals of Internal Medicine"},{"key":"BF03259895_CR52","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1016\/S0140-6736(77)90578-5","volume":"2","author":"R Esposito","year":"1977","unstructured":"Esposito R. Cimetidine and iron-deficiency anaemia. Lancet 2: 1132, 1977","journal-title":"Lancet"},{"key":"BF03259895_CR53","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1097\/00007611-198110000-00029","volume":"74","author":"BF Farber","year":"1981","unstructured":"Farber BF, Brody JP. Rapid development of aplastic anemia after intravenous chloramphenicol and cimetidine therapy. Southern Medical Journal 74: 1257\u20131258, 1981","journal-title":"Southern Medical Journal"},{"key":"BF03259895_CR54","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0140-6736(82)90417-2","volume":"1","author":"J Feely","year":"1982","unstructured":"Feely J, Guy E. Ranitidine also reduces liver blood flow. Lancet 1: 169, 1982","journal-title":"Lancet"},{"key":"BF03259895_CR55","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1056\/NEJM198103193041202","volume":"304","author":"J Feely","year":"1981","unstructured":"Feely J, Wilkinson GR, Wood AJJ. Reduction of liver blood flow and propranolol metabolism by cimetidine. New England Journal of Medicine 304: 692\u2013695, 1981","journal-title":"New England Journal of Medicine"},{"key":"BF03259895_CR56","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1056\/NEJM197611182952108","volume":"295","author":"EJ Feldman","year":"1976","unstructured":"Feldman EJ. Isenberg JL Effects of metiamide on gastric acid hypersecretion, steatorrhea and bone-marrow function in a patient with systemic mastocytosis. New England Journal of Medicine 295: 1178\u20131179, 1976","journal-title":"New England Journal of Medicine"},{"key":"BF03259895_CR57","first-page":"123","volume":"88","author":"R Fernandez-Rodriguez","year":"1987","unstructured":"Fernandez-Rodriguez R, Moreno-Sanchez D, De Cuenca Moron B, Martinez-Fernandez R. Leucopenia reversible asociada al uso de cimetidina. Medica Clinica (Barcelona) 88: 123, 1987","journal-title":"Medica Clinica (Barcelona)"},{"key":"BF03259895_CR58","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1136\/bmj.1.6116.818-a","volume":"1","author":"LP Fielding","year":"1978","unstructured":"Fielding LP, Chalmers DM, Chanarin I, Levi AJ. Inhibition of intrinsic factor secretion by cimetidine. British Medical Journal 1: 818\u2013819, 1978","journal-title":"British Medical Journal"},{"key":"BF03259895_CR59","first-page":"664","volume":"19","author":"J Fischer","year":"1985","unstructured":"Fischer J. Ranitidine and warfarin interaction. Drug Intelligence and Clinical Pharmacy 19: 664\u2013665, 1985","journal-title":"Drug Intelligence and Clinical Pharmacy"},{"key":"BF03259895_CR60","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/j.1365-2141.1980.tb05982.x","volume":"46","author":"JH Fitchen","year":"1980","unstructured":"Fitchen JH, Koeffler HP. Cimetidine and granulopoiesis: bone marrow culture studies in normal man and patients with cimetidine-associated neutropenia. British Journal of Haematology 46: 361\u2013366, 1980","journal-title":"British Journal of Haematology"},{"key":"BF03259895_CR61","first-page":"342","volume":"296","author":"D Fleischer","year":"1977","unstructured":"Fleischer D, Samloff IM. Cimetidine therapy in a patient with metiamide-induced agranulocytosis. New England Journal of Medicine 296: 342, 1977","journal-title":"New England Journal of Medicine"},{"key":"BF03259895_CR62","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1136\/bmj.2.6148.1367-a","volume":"2","author":"AC Flind","year":"1978","unstructured":"Flind AC. Cimetidine and oral anticoagulants. British Medical Journal 2: 1367, 1978","journal-title":"British Medical Journal"},{"key":"BF03259895_CR63","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/S0140-6736(75)91305-7","volume":"1","author":"JAH Forrest","year":"1975","unstructured":"Forrest JAH, Shearman DJC, Spence R, Celestin LR. Neutropenia associated with metiamide. Lancet 1: 392\u2013393, 1975","journal-title":"Lancet"},{"key":"BF03259895_CR64","doi-asserted-by":"crossref","first-page":"477","DOI":"10.7326\/0003-4819-106-3-477_1","volume":"106","author":"U Gafter","year":"1987","unstructured":"Gafter U, Komlos L, Weinstein T, Zevin D, Levi J. Thrombocytopenia, eosinophilia and ranitidine. Annals of Internal Medicine 106: 477, 1987","journal-title":"Annals of Internal Medicine"},{"key":"BF03259895_CR65","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1097\/00007890-198301000-00003","volume":"35","author":"RL Gamelli","year":"1983","unstructured":"Gamelli RL, Foster RS, Whisnant JK. Hematopoietic toxicity of cimetidine: reexamination using the antimetabolite azathioprine. Transplantation 35: 12\u201314, 1983","journal-title":"Transplantation"},{"key":"BF03259895_CR66","first-page":"228","volume":"31","author":"DC Garg","year":"1982","unstructured":"Garg DC, Weidler DJ, Jallad NS, Eshelman FN. The effects of ranitidine and cimetidine on hepatic blood flow. Clinical Pharmacology and Therapeutics 31: 228, 1982","journal-title":"Clinical Pharmacology and Therapeutics"},{"key":"BF03259895_CR67","first-page":"685","volume":"81","author":"JS Gelwan","year":"1986","unstructured":"Gelwan JS, Schmitz RL, Pellecchia C. Ranitidine and leukocytosis. American Journal of Gastroenterology 81: 685\u2013687, 1986","journal-title":"American Journal of Gastroenterology"},{"key":"BF03259895_CR68","doi-asserted-by":"crossref","first-page":"661","DOI":"10.5694\/j.1326-5377.1986.tb139552.x","volume":"145","author":"PR Gibson","year":"1986","unstructured":"Gibson PR, Pidcock ME. Immune-mediated thrombocytopenia associated with ranitidine therapy. Medical Journal of Australia 145: 661\u2013662, 1986","journal-title":"Medical Journal of Australia"},{"key":"BF03259895_CR69","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1097\/00007611-198202000-00030","volume":"75","author":"RE Glotzbach","year":"1982","unstructured":"Glotzbach RE. Cimetidine-induced thrombocytopenia. Southern Medical Journal 75: 232\u2013234, 1982","journal-title":"Southern Medical Journal"},{"key":"BF03259895_CR70","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/S0140-6736(63)91623-4","volume":"1","author":"A Goldberg","year":"1963","unstructured":"Goldberg A, Lochhead AC, Dagg JH. Histamine-fast achlorhydria and iron absorption. Lancet 1: 848\u2013850, 1963","journal-title":"Lancet"},{"key":"BF03259895_CR71","first-page":"2660","volume":"7","author":"E Gouffier","year":"1978","unstructured":"Gouffier E, Schnurmann D, Durepaire H, Vernant JP. Aplasie m\u00e9dullaire transitoire au cours d\u2019un traitement par la cim\u00e9tidine. Nouvelle Presse M\u00e9dicale 7: 2660, 1978","journal-title":"Nouvelle Presse M\u00e9dicale"},{"key":"BF03259895_CR72","first-page":"454","volume":"17","author":"DM Grasela","year":"1983","unstructured":"Grasela DM, Rocci ML, Rotmensch HH, Vlasses PH. Multiple dose cimetidine does not affect indocyanine green clearance. Drug Intelligence and Clinical Pharmacy 17: 454, 1983","journal-title":"Drug Intelligence and Clinical Pharmacy"},{"key":"BF03259895_CR73","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1182\/blood.V69.4.1204.1204","volume":"69","author":"C Grillot-Courvalin","year":"1986","unstructured":"Grillot-Courvalin C, Vinci G, Tsapis A, Dokhelar MC, Vainchenker W, et al. The syndrome of T8 hyperlymphocytosis: variation in phenotype and cytotoxic activities of granular cells and evaluation of their role in associated neutropenia. Blood 69: 1204\u20131210, 1986","journal-title":"Blood"},{"key":"BF03259895_CR74","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1002\/ajh.2830170308","volume":"17","author":"S Gross","year":"1984","unstructured":"Gross S, Worthington-White DA. Cimetidine suppression of CFU-C in males. American Journal of Hematology 17: 279\u2013286, 1984","journal-title":"American Journal of Hematology"},{"key":"BF03259895_CR75","doi-asserted-by":"crossref","first-page":"756","DOI":"10.3109\/00365528509089208","volume":"20","author":"B Hamborg","year":"1985","unstructured":"Hamborg B, Kittang E, Schjonsby H. The effect of ranitidine on the absorption of food cobalamins. Scandinavian Journal of Gastroenterology 20: 756\u2013758, 1985","journal-title":"Scandinavian Journal of Gastroenterology"},{"key":"BF03259895_CR76","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1111\/j.1365-2125.1982.tb01979.x","volume":"14","author":"J Harenberg","year":"1982","unstructured":"Harenberg J, Staiger C, De Vries JX, Walter E, Weber E, et al. Cimetidine does not increase the anticoagulant effect of phenprocoumon. British Journal of Clinical Pharmacology 14: 292\u2013293, 1982","journal-title":"British Journal of Clinical Pharmacology"},{"key":"BF03259895_CR77","first-page":"1604","volume":"310","author":"DC Harmon","year":"1984","unstructured":"Harmon DC, Shuman R. Ranitidine. New England Journal of Medicine 310: 1604, 1984","journal-title":"New England Journal of Medicine"},{"key":"BF03259895_CR78","first-page":"114","volume":"64","author":"R Hast","year":"1986","unstructured":"Hast R, Bernell P, Befrits R, Dowding C, Sj\u00f6gren AM. Decrease in helper (T4+) lymphocytes following cimetidine treatment for duodenal ulcer. Clinical and Experimental Immunology 64: 114\u2013118, 1986","journal-title":"Clinical and Experimental Immunology"},{"key":"BF03259895_CR79","first-page":"1604","volume":"310","author":"A Herrera","year":"1984","unstructured":"Herrera A, Solal-Celigny P, Dresch C, Vallin J, Bernades P. Ranitidine. New England Journal of Medicine 310: 1604\u20131605, 1984","journal-title":"New England Journal of Medicine"},{"key":"BF03259895_CR80","first-page":"733","volume":"69","author":"WA Hess","year":"1985","unstructured":"Hess WA, Kornblith PL. Combination of lomustine and cimetidine in the treatment of a patient with malignant glioblastoma: a case report. Cancer Treatment Reports 69: 733, 1985","journal-title":"Cancer Treatment Reports"},{"key":"BF03259895_CR81","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/S0140-6736(79)91701-X","volume":"2","author":"D Hetzel","year":"1979","unstructured":"Hetzel D, Birkett D, Miners J. Cimetidine interaction with warfarin. Lancet 2: 639, 1979","journal-title":"Lancet"},{"key":"BF03259895_CR82","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1136\/bmj.282.6275.1512","volume":"282","author":"DJ Hetzel","year":"1981","unstructured":"Hetzel DJ, Bochner F, Hallpike JF, Shearman DJC, Hann CS. Cimetidine interaction with phenytoin. British Medical Journal 282: 1512, 1981","journal-title":"British Medical Journal"},{"key":"BF03259895_CR83","first-page":"363","volume":"33","author":"M Hummer-Sigiel","year":"1985","unstructured":"Hummer-Sigiel M, Girard A, Mandoria JY, Colson T, Jacquier A. Thrombop\u00e9nie sous ranitidine et thiophenicol: responsabilit\u00e9 du thiophenicol. Cahiers d\u2019Anesth\u00e9siologie 33: 363\u2013365, 1985","journal-title":"Cahiers d\u2019Anesth\u00e9siologie"},{"issue":"134","key":"BF03259895_CR84","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3109\/00365528709090142","volume":"22","author":"TJ Humphries","year":"1987","unstructured":"Humphries TJ. Famotidine: a notable lack of drug interaction. Scandinavian Journal of Gastroenterology 22 (Suppl. 134): 55\u201360, 1987","journal-title":"Scandinavian Journal of Gastroenterology"},{"key":"BF03259895_CR85","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0140-6736(79)90054-0","volume":"2","author":"J Idvall","year":"1979","unstructured":"Idvall J. Cimetidine-associated thrombocytopenia. Lancet 2: 159, 1979","journal-title":"Lancet"},{"key":"BF03259895_CR86","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1111\/j.1365-2125.1986.tb02925.x","volume":"22","author":"Y Imai","year":"1986","unstructured":"Imai Y, Inada M, Tamura S, Kawata S, Minami Y, et al. Comparative effects of famotidine and cimetidine on 7-ethoxycoumarin O-deethylase activity in human livers. British Journal of Clinical Pharmacology 22: 495\u2013496, 1986","journal-title":"British Journal of Clinical Pharmacology"},{"key":"BF03259895_CR87","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1136\/bmj.280.6210.294","volume":"280","author":"AJ Isaacs","year":"1980","unstructured":"Isaacs AJ. Cimetidine and thrombocytopenia. British Medical Journal 280: 294, 1980","journal-title":"British Medical Journal"},{"key":"BF03259895_CR88","first-page":"805","volume":"72","author":"SK Iyer","year":"1980","unstructured":"Iyer SK, Chandrasekhara KL. Leukopenia with cimetidine. Journal of the National Medical Association 72: 805\u2013806, 1980","journal-title":"Journal of the National Medical Association"},{"key":"BF03259895_CR89","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1136\/gut.10.6.488","volume":"10","author":"A Jacobs","year":"1969","unstructured":"Jacobs A, Owen GM. Effect of gastric juice on iron absorption in patients with gastric atrophy. Gut 10: 488\u2013490, 1969","journal-title":"Gut"},{"key":"BF03259895_CR90","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1111\/j.1365-2141.1966.tb00159.x","volume":"12","author":"A Jacobs","year":"1966","unstructured":"Jacobs A, Rhodes J, Peters DK, Campbell H, Eakins JD. Gastric acidity and iron absorption. British Journal of Haematology 12: 728\u2013736, 1966","journal-title":"British Journal of Haematology"},{"key":"BF03259895_CR91","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/S0140-6736(78)90272-6","volume":"1","author":"C James","year":"1978","unstructured":"James C, Prout BJ. Marrow suppression and intravenous cimetidine. Lancet 1: 987, 1978","journal-title":"Lancet"},{"key":"BF03259895_CR92","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1016\/S0140-6736(77)90461-5","volume":"2","author":"NM Johnson","year":"1977","unstructured":"Johnson NM, Black AE, Hughes ASB, Clarke SW. Leucopenia with cimetidine. Lancet 2: 1226\u20131227, 1977","journal-title":"Lancet"},{"key":"BF03259895_CR93","doi-asserted-by":"crossref","first-page":"192","DOI":"10.7326\/0003-4819-92-2-192","volume":"92","author":"JL Jorizzo","year":"1980","unstructured":"Jorizzo JL, Sams WM, Jegasothy BV, Olansky J. Cimetidine as an immunomodulator: chronic mucocutaneous candidiasis as a model. Annals of Internal Medicine 92: 192\u2013195, 1980","journal-title":"Annals of Internal Medicine"},{"key":"BF03259895_CR94","first-page":"1128","volume":"108","author":"HJ Keller","year":"1983","unstructured":"Keller HJ, Kirste G, Wilms H. Cimetidin-induzierte Leukopenie nach Nierentransplantation. Deutsche Medizinische Wochenschrift 108: 1128\u20131129, 1983","journal-title":"Deutsche Medizinische Wochenschrift"},{"key":"BF03259895_CR95","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1093\/milmed\/145.12.853","volume":"145","author":"N Khokhar","year":"1980","unstructured":"Khokhar N, Akavaram NR. Cimetidine-induced leukopenia: case reports. Military Medicine 145: 853\u2013855, 1980","journal-title":"Military Medicine"},{"key":"BF03259895_CR96","doi-asserted-by":"crossref","first-page":"493","DOI":"10.2165\/00003088-198409060-00002","volume":"9","author":"W Kirch","year":"1984","unstructured":"Kirch W, Hoensch H, Janisch HD. Interactions and non-interactions with ranitidine. Clinical Pharmacokinetics 9: 493\u2013510, 1984","journal-title":"Clinical Pharmacokinetics"},{"key":"BF03259895_CR97","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1097\/00007611-198003000-00038","volume":"73","author":"CS Kitchens","year":"1980","unstructured":"Kitchens CS. Lack of antiplatelet effect of cimetidine in hemophiliacs. Southern Medical Journal 73: 391\u2013392, 1980","journal-title":"Southern Medical Journal"},{"key":"BF03259895_CR98","doi-asserted-by":"crossref","first-page":"579","DOI":"10.7326\/0003-4819-88-4-579_2","volume":"88","author":"SA Klotz","year":"1978","unstructured":"Klotz SA, Kay BF. Cimetidine and agranulocytosis. Annals of Internal Medicine 88: 579\u2013580, 1978","journal-title":"Annals of Internal Medicine"},{"issue":"136","key":"BF03259895_CR99","doi-asserted-by":"crossref","first-page":"18","DOI":"10.3109\/00365528709094481","volume":"22","author":"U Klotz","year":"1987","unstructured":"Klotz U. Lack of effect of nizatidine on drug metabolism. Scandinavian Journal of Gastroenterology 22 (Suppl. 136): 18\u201323,1987","journal-title":"Scandinavian Journal of Gastroenterology"},{"key":"BF03259895_CR100","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/0016-5085(82)90127-5","volume":"82","author":"RG Knodell","year":"1982","unstructured":"Knodell RG, Holtzman JL, Crankshaw DL, Steele NM, Stanley LN. Drug metabolism by rat and human hepatic microsomes in response to interaction with H2-receptor antagonists. Gastroenterology 82: 84\u201388, 1982","journal-title":"Gastroenterology"},{"key":"BF03259895_CR101","doi-asserted-by":"crossref","first-page":"145","DOI":"10.2165\/00003495-198530020-00003","volume":"30","author":"DG Lambie","year":"1985","unstructured":"Lambie DG, Johnson RH. Drugs and folate metabolism. Drugs 30: 145\u2013155, 1985","journal-title":"Drugs"},{"key":"BF03259895_CR102","first-page":"385","volume":"37","author":"J Lavarenne","year":"1982","unstructured":"Lavarenne J, Maradeix B. Atteintes de la lign\u00e9e blanche et cimetidine. Th\u00e9rapie 37: 385\u2013388, 1982","journal-title":"Th\u00e9rapie"},{"key":"BF03259895_CR103","first-page":"83","volume":"35","author":"J Lavarenne","year":"1980","unstructured":"Lavarenne J, Moreau C. Les effets ind\u00e9sirables de la cim\u00e9tidine: travail coop\u00e9ratif des centres de pharmacovigilance hospitali\u00e8re, bilan des observations et confrontation aux donn\u00e9es de la litt\u00e9rature. Th\u00e9rapie 35: 83\u2013112, 1980","journal-title":"Th\u00e9rapie"},{"key":"BF03259895_CR104","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1038\/clpt.1981.200","volume":"30","author":"PA Lebert","year":"1981","unstructured":"Lebert PA, McLeod SM, Mahon WA, Soldin SJ, Vandenberghe HM. Ranitidine kinetics and dynamics, I: oral dose studies. Clinical Pharmacology and Therapeutics 30: 539\u2013544, 1981","journal-title":"Clinical Pharmacology and Therapeutics"},{"key":"BF03259895_CR105","first-page":"389","volume":"37","author":"P Lederlin","year":"1982","unstructured":"Lederlin P, Witz F, Colomb JN, Rumilly F, Eisenmann JC, et al. Aspects cliniques, \u00e9tiologiques et \u00e9volutifs des agranulocytoses aigues m\u00e9dicamenteuses: \u00e0 propos de 42 observations. Th\u00e9rapie 37: 389\u2013393, 1982","journal-title":"Th\u00e9rapie"},{"key":"BF03259895_CR106","first-page":"44","volume":"13","author":"C Legendre","year":"1984","unstructured":"Legendre C, Canaud B, Beraud JJ, Brunin JL, Balmes JL, et al. Neutropenie s\u00e9v\u00e8re, r\u00e9cidivante et reversible induite par la cim\u00e9tidine. Presse M\u00e9dicale 13: 44, 1984","journal-title":"Presse M\u00e9dicale"},{"key":"BF03259895_CR107","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1136\/pgmj.58.681.443","volume":"58","author":"DS Lewis","year":"1982","unstructured":"Lewis DS, Beck ER. Reversible agranulocytosis in association with cimetidine and hepatic failure. Postgraduate Medical Journal 58: 443\u2013444, 1982","journal-title":"Postgraduate Medical Journal"},{"key":"BF03259895_CR108","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/S0090-9556(25)08989-5","volume":"14","author":"JH Lin","year":"1986","unstructured":"Lin JH, Cocchetto DM, Yeh KC, Dugan DE. Comparative effects of H2-receptor antagonists on drug interaction in rats. Drug Metabolism and Disposition 14: 649\u2013653, 1986","journal-title":"Drug Metabolism and Disposition"},{"key":"BF03259895_CR109","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1097\/00007611-198103000-00027","volume":"74","author":"GE Linhardt","year":"1981","unstructured":"Linhardt GE, Gadacz TR. Prolonged WBC depression after cimetidine in a patient with chronic myelogenous leukemia. Southern Medical Journal 74: 353\u2013355, 1981","journal-title":"Southern Medical Journal"},{"key":"BF03259895_CR110","doi-asserted-by":"crossref","first-page":"566","DOI":"10.7326\/0003-4819-108-4-566","volume":"108","author":"AF List","year":"1988","unstructured":"List AF, Beaird DH, Kummet T. Ranitidine-induced granulocytopenia: recurrence with cimetidine administration. Annals of Internal Medicine 108: 566\u2013567, 1988","journal-title":"Annals of Internal Medicine"},{"key":"BF03259895_CR111","doi-asserted-by":"crossref","first-page":"317","DOI":"10.7326\/0003-4819-91-2-317_2","volume":"91","author":"GO Littlejohn","year":"1979","unstructured":"Littlejohn GO, Urowitz MB. Cimetidine, lupus erythematosus, and granulocytopenia. Annals of Internal Medicine 91: 317\u2013318, 1979","journal-title":"Annals of Internal Medicine"},{"key":"BF03259895_CR112","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/S0140-6736(78)91233-3","volume":"1","author":"A Lopez-Luque","year":"1978","unstructured":"Lopez-Luque A, Rodriguez-Cuartero A, Perez-Galvez N, Pomares-Mora J, Pena-Yanez A. Cimetidine and bone-marrow toxicity. Lancet 1: 444, 1978","journal-title":"Lancet"},{"key":"BF03259895_CR113","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/0016-5085(78)90786-2","volume":"74","author":"KW Ma","year":"1978","unstructured":"Ma KW, Brown DC, Masler DS, Silvis SE. Effects of renal failure on blood levels of cimetidine. Gastroenterology 74: 473\u2013477, 1978","journal-title":"Gastroenterology"},{"key":"BF03259895_CR114","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1177\/106002808301700209","volume":"17","author":"HJ Mann","year":"1983","unstructured":"Mann HJ, Schneider JR, Miller JB, Delaney JP. Cimetidine-associated thrombocytopenia. Drug Intelligence and Clinical Pharmacy 17: 126\u2013128, 1983","journal-title":"Drug Intelligence and Clinical Pharmacy"},{"key":"BF03259895_CR115","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1097\/00007611-198210000-00038","volume":"75","author":"DD Mar","year":"1982","unstructured":"Mar DD, Brandstetter RD, Miskovitz PF, Fotino M. Cimetidine-induced, immune-mediated leukopenia and thrombocytopenia. Southern Medical Journal 75: 1283\u20131285, 1982","journal-title":"Southern Medical Journal"},{"key":"BF03259895_CR116","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/clpt.1983.158","volume":"34","author":"ML Mashford","year":"1983","unstructured":"Mashford ML, Harman PJ, Morphett BJ, Breen KJ, Desmond PV. Ranitidine does not affect chlormethiazole or indocyanine green disposition. Clinical Pharmacology and Therapeutics 34: 231\u2013233, 1983","journal-title":"Clinical Pharmacology and Therapeutics"},{"key":"BF03259895_CR117","first-page":"864","volume":"300","author":"JL McDaniel","year":"1979","unstructured":"McDaniel JL, Stein JJ. Thrombocytopenia with cimetidine therapy. New England Journal of Medicine 300: 864, 1979","journal-title":"New England Journal of Medicine"},{"key":"BF03259895_CR118","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1177\/014107687907201208","volume":"72","author":"WAW McGowan","year":"1979","unstructured":"McGowan WAW. Safety of cimetidine in obstetric patients. Journal of the Royal Society of Medicine 72: 902\u2013907, 1979","journal-title":"Journal of the Royal Society of Medicine"},{"key":"BF03259895_CR119","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/S0140-6736(77)91709-3","volume":"1","author":"CGA McGregor","year":"1977","unstructured":"McGregor CGA, Cochran AJ, Ogg LJ, Gray GR, Smith IS, et al. Immunological and other laboratory studies of patients receiving short-term cimetidine therapy. Lancet 1: 122\u2013123, 1977","journal-title":"Lancet"},{"key":"BF03259895_CR120","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1136\/bmj.281.6246.1005-b","volume":"281","author":"DP Mikhailidis","year":"1980","unstructured":"Mikhailidis DP, Mikhailidis AM, Dandona P. Prevention or cure for stress-induced gastrointestinal bleeding. British Medical Journal 281: 1005\u20131006, 1980","journal-title":"British Medical Journal"},{"key":"BF03259895_CR121","first-page":"118","volume":"4","author":"R Mohammed","year":"1981","unstructured":"Mohammed R, Clark JS, Adams JF, Hearns JB, Crean GP. The effect of ranitidine hydrochloride, a new histamine H2-receptor antagonist, on intrinsic factor secretion. Clinical Therapeutics 4: 118\u2013120, 1981","journal-title":"Clinical Therapeutics"},{"key":"BF03259895_CR122","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/BF01300694","volume":"31","author":"M Morichau-Beauchant","year":"1986","unstructured":"Morichau-Beauchant M, Houin, G, Mavier P, Alexandre C, Dhumeaux D. Pharmacokinetics and bioavailability of ranitidine in normal subjects and cirrhotic patients. Digestive Diseases and Sciences 31: 113\u2013118, 1986","journal-title":"Digestive Diseases and Sciences"},{"key":"BF03259895_CR123","first-page":"A1338","volume":"28","author":"R Mountford","year":"1987","unstructured":"Mountford R, Preece AW, Jones R, Grove E, Cottrell J. Effect of treatment with famotidine on T-lymphocyte populations and activity in duodenal ulcer patients. Gut 28: A1338\u2013A1339, 1987","journal-title":"Gut"},{"key":"BF03259895_CR124","first-page":"359","volume":"82","author":"A Nagler","year":"1987","unstructured":"Nagler A, Rozenbaum H, Enat R, Tatarsky I, Katz R, et al. Immune basis for cimetidine-induced pancytopenia. American Journal of Gastroenterology 82: 359\u2013361, 1987","journal-title":"American Journal of Gastroenterology"},{"key":"BF03259895_CR125","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1136\/bmj.295.6593.333-a","volume":"295","author":"T Nakatani","year":"1987","unstructured":"Nakatani T. Granulocytopenia associated with ranitidine in a patient with renal transplant. British Medical Journal 295: 333, 1987","journal-title":"British Medical Journal"},{"key":"BF03259895_CR126","first-page":"481","volume":"3","author":"O Nouel","year":"1979","unstructured":"Nouel O, Pariente EA, Slaoui H, Renoux M. Agranulocytose \u00e0 la cim\u00e9tidine: un accident immuno-allergique? Gastroenterologie Clinique et Biologique 3: 481, 1979","journal-title":"Gastroenterologie Clinique et Biologique"},{"key":"BF03259895_CR127","first-page":"415","volume":"82","author":"K Ohnishi","year":"1987","unstructured":"Ohnishi K, Saito M, Nomura F, Okuda K, Suzuki N, et al. Effect of famotidine on hepatic hemodynamics and peptic ulcer. American Journal of Gastroenterology 82: 415\u2013418, 1987","journal-title":"American Journal of Gastroenterology"},{"key":"BF03259895_CR128","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1001\/archinte.1984.00350170143024","volume":"144","author":"RA O\u2019Reilly","year":"1984","unstructured":"O\u2019Reilly RA. Comparative interaction of cimetidine and ranitidine with racemic warfarin in man. Archives of Internal Medicine 144: 989\u2013991, 1984","journal-title":"Archives of Internal Medicine"},{"key":"BF03259895_CR129","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1016\/0016-5085(80)90450-3","volume":"79","author":"RV Patwardhan","year":"1980","unstructured":"Patwardhan RV, Yarborough GW, Desmond PV, Johnson RF, Schenker S, et al. Cimetidine spares the glucuronidation of lorazepam and oxazepam. Gastroenterology 79: 912\u2013916, 1980","journal-title":"Gastroenterology"},{"key":"BF03259895_CR130","first-page":"900","volume":"1","author":"NR Peden","year":"1981","unstructured":"Peden NR, Boyds EJS, Brown RA, Gibbs JH, Potts RC, et al. Cimetidine, the immune system, and cancer. Lancet 1: 900\u2013901, 1981","journal-title":"Lancet"},{"key":"BF03259895_CR131","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1136\/gut.23.5.398","volume":"23","author":"NR Peden","year":"1982","unstructured":"Peden NR, Robertson AJ, Boyd EJS, Brown RA, Gibbs JH, et al. Mitogen stimulation of peripheral blood lymphocytes of duodenal ulcer patients during treatment with cimetidine or ranitidine. Gut 23: 398\u2013403, 1982","journal-title":"Gut"},{"key":"BF03259895_CR132","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1097\/00004836-198310000-00006","volume":"5","author":"LD Petz","year":"1983","unstructured":"Petz LD, Gitlin N, Grant K, Rodvien R, Brotman M. Cimetidine-induced hemolytic anemia: the fallacy of clinical associations. Journal of Clinical Gastroenterology 5: 405\u2013409, 1983","journal-title":"Journal of Clinical Gastroenterology"},{"key":"BF03259895_CR133","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1001\/archinte.1979.03630420070022","volume":"139","author":"DN Posnett","year":"1979","unstructured":"Posnett DN, Stein RS, Graber SE, Krantz SB. Cimetidine-induced neutropenia: a possible dose-related phenomenon. Archives of Internal Medicine 139: 584\u2013586, 1979","journal-title":"Archives of Internal Medicine"},{"issue":"5B","key":"BF03259895_CR134","first-page":"57","volume":"77","author":"JR Powell","year":"1984","unstructured":"Powell JR, Donn KH. Histamine H2-antagonist drug interactions in perspective: mechanistic concepts and clinical implications. American Journal of Medicine 77 (Suppl. 5B): 57\u201384, 1984","journal-title":"American Journal of Medicine"},{"key":"BF03259895_CR135","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/BF00561588","volume":"18","author":"J Puurunen","year":"1980","unstructured":"Puurunen J, Sotaniemi E, Pelkonen O. Effect of cimetidine on microsomal drug metabolism in man. European Journal of Clinical Pharmacology 18: 185\u2013187, 1980","journal-title":"European Journal of Clinical Pharmacology"},{"key":"BF03259895_CR136","doi-asserted-by":"crossref","first-page":"795","DOI":"10.7326\/0003-4819-91-5-795","volume":"91","author":"R Rate","year":"1979","unstructured":"Rate R, Bonnell M, Chervenak C, Pavinich G. Cimetidine and hematologic effects. Annals of Internal Medicine 91: 795, 1979","journal-title":"Annals of Internal Medicine"},{"key":"BF03259895_CR137","first-page":"232","volume":"91","author":"J Reddy","year":"1980","unstructured":"Reddy J, Bailey RR. Cimetidine and thrombocytopenia. New Zealand Medical Journal 91: 232, 1980","journal-title":"New Zealand Medical Journal"},{"key":"BF03259895_CR138","first-page":"2586","volume":"10","author":"J Reiffers","year":"1981","unstructured":"Reiffers J, Piquet Y, Roussy P, Boisseau C, Couzigou P, et al. Thrombopenie apr\u00e8s traitement par cim\u00e9tidine. Nouvelle Presse M\u00e9dicale 10: 2586\u20132587, 1981","journal-title":"Nouvelle Presse M\u00e9dicale"},{"key":"BF03259895_CR139","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/0006-2952(83)90584-1","volume":"32","author":"PEB Reilly","year":"1983","unstructured":"Reilly PEB, Carrington LE, Winzor DJ. The interaction of cimetidine with rat liver microsomes. Biochemical Pharmacology 32: 831\u2013835, 1983","journal-title":"Biochemical Pharmacology"},{"key":"BF03259895_CR140","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3109\/00498258209052450","volume":"12","author":"S Rendic","year":"1982","unstructured":"Rendic S, Alebic-Kolbah T, Kajfez F, Ruf HH. Interaction of ranitidine with liver microsomes. Xenobiotica 12: 9\u201317, 1982","journal-title":"Xenobiotica"},{"key":"BF03259895_CR141","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0090-9556(25)07987-5","volume":"11","author":"S Rendic","year":"1983","unstructured":"Rendic S, Kajfez F, Ruf HH. Characterization of cimetidine, ranitidine and related structures\u2019 interaction with cytochrome P-450. Drug Metabolism and Disposition 11: 137\u2013142, 1983","journal-title":"Drug Metabolism and Disposition"},{"key":"BF03259895_CR142","doi-asserted-by":"crossref","first-page":"555","DOI":"10.3109\/00498257909042321","volume":"9","author":"S Rendic","year":"1979","unstructured":"Rendic S, Sunjic V, Toso R, Kajfez F, Ruf HH. Interaction of cimetidine with liver microsomes. Xenobiotica 9: 555\u2013564, 1979","journal-title":"Xenobiotica"},{"key":"BF03259895_CR143","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1007\/BF01308047","volume":"25","author":"JE Richter","year":"1980","unstructured":"Richter JE, Gerhardt DC, Pasquale DN, Castell DO. Cimetidine and hematologic suppression: things are not always as they appear. Digestive Diseases and Sciences 25: 960\u2013963, 1980","journal-title":"Digestive Diseases and Sciences"},{"key":"BF03259895_CR144","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S0140-6736(79)91637-4","volume":"2","author":"B Rotoli","year":"1979","unstructured":"Rotoli B, Formisano S, Alfinito F. Autoimmune haemolytic anaemia associated with cimetidine. Lancet 2: 583, 1979","journal-title":"Lancet"},{"key":"BF03259895_CR145","first-page":"261","volume-title":"Cimetidine in the 80s","author":"D Rowley-Jones","year":"1981","unstructured":"Rowley-Jones D, Flind AC. Continuing evaluation of the safety of cimetidine. In Baron (Ed.) Cimetidine in the 80s, pp. 261\u2013269, Churchill Livingstone, Edinburgh, 1981"},{"key":"BF03259895_CR146","doi-asserted-by":"crossref","first-page":"2760","DOI":"10.4049\/jimmunol.138.9.2760","volume":"138","author":"DM Sahasrabudhe","year":"1987","unstructured":"Sahasrabudhe DM, McCune CS, O\u2019Donnell RW, Henshaw EC. Inhibition of suppressor T lymphocytes (Ts) by cimetidine. Journal of Immunology 138: 2760\u20132763, 1987","journal-title":"Journal of Immunology"},{"issue":"134","key":"BF03259895_CR147","doi-asserted-by":"crossref","first-page":"34","DOI":"10.3109\/00365528709090138","volume":"22","author":"K Saigenji","year":"1987","unstructured":"Saigenji K, Fukutomi H, Nakazawa S. Famotidine: postmarketing clinical experience. Scandinavian Journal of Gastroenterology 22 (Suppl. 134): 34\u201340, 1987","journal-title":"Scandinavian Journal of Gastroenterology"},{"key":"BF03259895_CR148","doi-asserted-by":"crossref","first-page":"129","DOI":"10.3109\/00365528209181056","volume":"17","author":"IL Salom","year":"1982","unstructured":"Salom IL, Silvis SE, Doscherholmen A. Effect of cimetidine on the absorption of vitamin B12. Scandinavian Journal of Gastroenterology 17: 129\u2013131, 1982","journal-title":"Scandinavian Journal of Gastroenterology"},{"key":"BF03259895_CR149","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1007\/BF01315601","volume":"30","author":"Y Sasaki","year":"1985","unstructured":"Sasaki Y, Hayashi N, Kasahara A, Matsuda Y, Furusawa S, et al. Influence of ranitidine on hepatic blood flow assessed by organ-reflectance spectrophotometer and pulse-doppler ultrasonic flowmeter. Digestive Diseases and Sciences 30: 1043\u20131048, 1985","journal-title":"Digestive Diseases and Sciences"},{"key":"BF03259895_CR150","doi-asserted-by":"crossref","first-page":"151","DOI":"10.7326\/0003-4819-93-1-151_3","volume":"93","author":"E Sazie","year":"1980","unstructured":"Sazie E, Jaffe JP. Severe granulocytopenia with cimetidine and phenytoin. Annals of Internal Medicine 93: 151\u2013152, 1980","journal-title":"Annals of Internal Medicine"},{"key":"BF03259895_CR151","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1038\/clpt.1981.104","volume":"29","author":"JJ Schentag","year":"1981","unstructured":"Schentag JJ, Cerra FB, Calleri GM, Leising ME, French MA, et al. Age, disease, and cimetidine disposition in healthy subjects and chronically ill patients. Clinical Pharmacology and Therapeutics 29: 737\u2013743, 1981","journal-title":"Clinical Pharmacology and Therapeutics"},{"key":"BF03259895_CR152","first-page":"2982","volume":"8","author":"J Schmitt","year":"1979","unstructured":"Schmitt J, Jacquier A, Huttin B, Lambert H, Baille N, et al. Pancytopenie aigue avec atteinte m\u00e9dullaire au cours d\u2019un traitement par la cim\u00e9tidine. Nouvelle Presse M\u00e9dicale 8: 2982, 1979","journal-title":"Nouvelle Presse M\u00e9dicale"},{"key":"BF03259895_CR153","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0002-9343(84)90758-7","volume":"76","author":"AJ Sedman","year":"1984","unstructured":"Sedman AJ. Cimetidine-drug interactions. American Journal of Medicine 76: 109\u2013114, 1984","journal-title":"American Journal of Medicine"},{"key":"BF03259895_CR154","first-page":"330","volume":"135","author":"HP Selker","year":"1981","unstructured":"Selker HP, Rosenbloom BE, Weinstein IM. Cimetidine and cytopenia. Western Journal of Medicine 135: 330\u2013336, 1981","journal-title":"Western Journal of Medicine"},{"key":"BF03259895_CR155","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1111\/j.1365-2125.1981.tb01308.x","volume":"12","author":"MJ Serlin","year":"1981","unstructured":"Serlin MJ, Sibeon RG, Breckenridge AM. Lack of effect of ranitidine on warfarin action. British Journal of Clinical Pharmacology 12: 791\u2013794, 1981","journal-title":"British Journal of Clinical Pharmacology"},{"key":"BF03259895_CR156","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S0140-6736(79)90340-4","volume":"2","author":"MJ Serlin","year":"1979","unstructured":"Serlin MJ, Sibeon RG, Mossman S, Breckenridge AM, Williams JRB, et al. Cimetidine: interaction with oral anticoagulants in man. Lancet 2: 317\u2013319, 1979","journal-title":"Lancet"},{"key":"BF03259895_CR157","doi-asserted-by":"crossref","first-page":"128","DOI":"10.7326\/0003-4819-104-1-128_1","volume":"104","author":"LI Shields","year":"1986","unstructured":"Shields LI, Files JA, Doll DC, Greenberg BR. Ranitidine and agranulocytosis. Annals of Internal Medicine 104: 128, 1986","journal-title":"Annals of Internal Medicine"},{"key":"BF03259895_CR158","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1007\/BF02455993","volume":"32","author":"DA Sica","year":"1987","unstructured":"Sica DA, Comstock T, Harford A, Eshelman F. Ranitidine pharmacokinetics in continuous ambulatory peritoneal dialysis. European Journal of Clinical Pharmacology 32: 587\u2013591, 1987","journal-title":"European Journal of Clinical Pharmacology"},{"key":"BF03259895_CR159","doi-asserted-by":"crossref","first-page":"348","DOI":"10.7326\/0003-4819-90-3-348","volume":"90","author":"BA Silver","year":"1979","unstructured":"Silver BA, Bell WR, Cimetidine potentiation of the hypoprothrombinemic effect of warfarin. Annals of Internal Medicine 90: 348\u2013349, 1979","journal-title":"Annals of Internal Medicine"},{"key":"BF03259895_CR160","first-page":"289","volume":"33","author":"A Sinco","year":"1981","unstructured":"Sinco A, Conte G, Ambriz R, Aviles A, Morales MR, et al. Cimetidina y neutropenia transitoria en un paciente con hemophilia. Revista de Investigacion Clinica (Mexico) 33: 289\u2013291, 1981","journal-title":"Revista de Investigacion Clinica (Mexico)"},{"key":"BF03259895_CR161","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/S0016-5085(81)80013-3","volume":"81","author":"BS Skikne","year":"1981","unstructured":"Skikne BS, Lynch SR, Cook JD. Role of gastric acid in iron food absorption. Gastroenterology 81: 1068\u20131071, 1981","journal-title":"Gastroenterology"},{"key":"BF03259895_CR162","doi-asserted-by":"crossref","first-page":"44","DOI":"10.2165\/00003088-198815010-00004","volume":"15","author":"SR Smith","year":"1988","unstructured":"Smith SR, Kendall MJ. Ranitidine versus cimetidine: a comparison of their potential to cause clinically important drug interactions. Clinical Pharmacokinetics 15: 44\u201356, 1988","journal-title":"Clinical Pharmacokinetics"},{"key":"BF03259895_CR163","first-page":"2152","volume":"125","author":"AJPM Smout","year":"1981","unstructured":"Smout AJPM, Bakker B. Agranulocytose door cimetidine. Nederlands Tijdschrift voor Geneeskunde (Amsterdam) 125: 2152\u20132154, 1981","journal-title":"Nederlands Tijdschrift voor Geneeskunde (Amsterdam)"},{"key":"BF03259895_CR164","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1111\/j.1365-2125.1979.tb04655.x","volume":"7","author":"A Somogyi","year":"1979","unstructured":"Somogyi A, Gugler R. Cimetidine excretion into breast milk. British Journal of Clinical Pharmacology 7: 627\u2013629, 1979","journal-title":"British Journal of Clinical Pharmacology"},{"key":"BF03259895_CR165","doi-asserted-by":"crossref","first-page":"23","DOI":"10.2165\/00003088-198207010-00002","volume":"7","author":"A Somogyi","year":"1982","unstructured":"Somogyi A, Gugler R. Drug interactions with cimetidine. Clinical Pharmacokinetics 7: 23\u201341, 1982","journal-title":"Clinical Pharmacokinetics"},{"key":"BF03259895_CR166","doi-asserted-by":"crossref","first-page":"321","DOI":"10.2165\/00003088-198712050-00002","volume":"12","author":"A Somogyi","year":"1987","unstructured":"Somogyi A, Muirhead M. Pharmacokinetic interactions of cimetidine 1987. Clinical Pharmacokinetics 12: 321\u2013366, 1987","journal-title":"Clinical Pharmacokinetics"},{"key":"BF03259895_CR167","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/clpt.1981.30","volume":"29","author":"J Sonne","year":"1981","unstructured":"Sonne J, Poulsen HE, Dossing M, Larsen NE, Andreasen PB. Cimetidine clearance and bioavailability in hepatic cirrhosis. Clinical Pharmacology and Therapeutics 29: 191\u2013197, 1981","journal-title":"Clinical Pharmacology and Therapeutics"},{"key":"BF03259895_CR168","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1177\/106002808301700205","volume":"17","author":"EM Sorkin","year":"1983","unstructured":"Sorkin EM, Darvey DL. Review of cimetidine drug interactions. Drug Intelligence and Clinical Pharmacy 17: 110\u2013120, 1983","journal-title":"Drug Intelligence and Clinical Pharmacy"},{"key":"BF03259895_CR169","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/0016-5085(82)90128-7","volume":"82","author":"KV Speeg","year":"1982","unstructured":"Speeg KV, Patwardhan RV, Avant GR, Mitchell MC, Schenker S. Inhibition of microsomal drug metabolism by histamine H2-receptor antagonists studied in vivo and in vitro in rodents. Gastroenterology 82: 89\u201396, 1982","journal-title":"Gastroenterology"},{"key":"BF03259895_CR170","first-page":"141","volume":"134","author":"R Spinka","year":"1984","unstructured":"Spinka R, Honetz N. Akute granulozytopenie unter cimetidin. Wiener Medizinische Wochenschrift 134: 141\u2013145, 1984","journal-title":"Wiener Medizinische Wochenschrift"},{"key":"BF03259895_CR171","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1136\/bmj.291.6510.1687","volume":"291","author":"RT Spychal","year":"1985","unstructured":"Spychal RT, Wickham NWR. Thrombocytopenia associated with ranitidine. British Medical Journal 291: 1687, 1985","journal-title":"British Medical Journal"},{"key":"BF03259895_CR172","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1097\/00007611-198103000-00010","volume":"73","author":"RS Stein","year":"1981","unstructured":"Stein RS, Howard CA. Clinical assessment of cimetidine myelotoxicity. Southern Medical Journal 73: 293\u2013294, 1981","journal-title":"Southern Medical Journal"},{"key":"BF03259895_CR173","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1007\/BF01308137","volume":"25","author":"WM Steinberg","year":"1980","unstructured":"Steinberg WM, King CE, Toskes PP. Malabsorption of protein-bound cobalamin but not unbound cobalamin during cimetidine administration. Digestive Diseases and Sciences 25: 188\u2013192, 1980","journal-title":"Digestive Diseases and Sciences"},{"key":"BF03259895_CR174","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/0002-9610(74)90169-X","volume":"128","author":"AM Streeter","year":"1974","unstructured":"Streeter AM, Duraiappah B, Boyle R, O\u2019Neill BJ, Pheils MT. Malabsorption of vitamin B12 after vagotomy. American Journal of Surgery 128: 340\u2013343, 1974","journal-title":"American Journal of Surgery"},{"key":"BF03259895_CR175","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/BF01308115","volume":"27","author":"AM Streeter","year":"1982","unstructured":"Streeter AM, Goulston KJ, Bathur FA, Hilmer RS, Crane GG, et al. Cimetidine and malabsorption of cobalamin. Digestive Diseases and Sciences 27: 13\u201316, 1982","journal-title":"Digestive Diseases and Sciences"},{"key":"BF03259895_CR176","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/BF00543332","volume":"28","author":"T Takabatake","year":"1985","unstructured":"Takabatake T, Ohta H, Maekawa M, Yamamoto Y, Ishida Y, et al. Pharmacokinetics of famotidine, a new H2-receptor antagonist, in relation to renal function. European Journal of Clinical Pharmacology 28: 327\u2013331, 1985","journal-title":"European Journal of Clinical Pharmacology"},{"key":"BF03259895_CR177","first-page":"156","volume":"70","author":"D Tan-Ngamtrong","year":"1987","unstructured":"Tan-Ngamtrong D, Hitanant S, Vanasin B. Auto-immune hemolytic anemia during treatment with cimetidine. Journal of the Medical Association of Thailand 70: 156\u2013159, 1987","journal-title":"Journal of the Medical Association of Thailand"},{"key":"BF03259895_CR178","first-page":"397","volume":"49","author":"RK Teichmann","year":"1978","unstructured":"Teichmann RK, Zumtobel V, Heberer G. Agranulozytose durch cimetidin. Chirurg 49: 397\u2013398, 1978","journal-title":"Chirurg"},{"key":"BF03259895_CR179","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1111\/j.1365-2125.1987.tb03117.x","volume":"23","author":"R Testa","year":"1987","unstructured":"Testa R, Grasso A, Dagnino F, Ibba R, Varagona G, et al. Famotidine does not affect indocyanine green disposition and serum bile acid levels in healthy subjects. British Journal of Clinical Pharmacology 23: 779\u2013780, 1987","journal-title":"British Journal of Clinical Pharmacology"},{"key":"BF03259895_CR180","first-page":"829","volume":"11","author":"P Texereau","year":"1987","unstructured":"Texereau P, Ancelin P, Briaud M, Moussie D. Un cas d\u2019agranulocytose aigue chez un malade trait\u00e9 par ranitidine. Gastroenterologie Clinique et Biologique 11: 829\u2013830, 1987","journal-title":"Gastroenterologie Clinique et Biologique"},{"key":"BF03259895_CR181","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1007\/BF00542424","volume":"30","author":"HHW Thijssen","year":"1986","unstructured":"Thijssen HHW, Janssen GMJ, Baars LGM. Lack of effect of cimetidine on pharmacodynamics and kinetics of single oral doses of R- and S-acenocoumarol. European Journal of Clinical Pharmacology 30: 619\u2013623, 1986","journal-title":"European Journal of Clinical Pharmacology"},{"key":"BF03259895_CR182","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1177\/106002808501900510","volume":"19","author":"M Tishler","year":"1985","unstructured":"Tishler M, Abramov AL. Cimetidine-induced eosinophilia. Drug Intelligence and Clinical Pharmacy 19: 377\u2013378, 1985","journal-title":"Drug Intelligence and Clinical Pharmacy"},{"key":"BF03259895_CR183","first-page":"881","volume":"9","author":"K Tomioka","year":"1983","unstructured":"Tomioka K, Yamada T, Tachikawa S. Effects of famotidine (YM-11170), an H2-receptor antagonist on in vivo immediate and delayed type hypersensitivity reactions and antibody formation. Drugs under Experimental and Clinical Research 9: 881\u2013889, 1983","journal-title":"Drugs under Experimental and Clinical Research"},{"key":"BF03259895_CR184","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1002\/jps.2600651122","volume":"65","author":"GL Tong","year":"1976","unstructured":"Tong GL, Lien EJ. Biotransformation of drugs: quantitative structure-activity relationships for barbiturates, tertiary amines and substituted imidazoles. Journal of Pharmaceutical Science 65: 1651\u20131654, 1976","journal-title":"Journal of Pharmaceutical Science"},{"key":"BF03259895_CR185","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1001\/archinte.1980.00330190135050","volume":"140","author":"B Tonkonow","year":"1980","unstructured":"Tonkonow B, Hoffman R. Aplastic anemia and cimetidine. Archives of Internal Medicine 140: 1123\u20131124, 1980","journal-title":"Archives of Internal Medicine"},{"key":"BF03259895_CR186","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/BF00542190","volume":"32","author":"S Toon","year":"1987","unstructured":"Toon S, Hopkins KJ. Garstang FM, Rowland M. Comparative effects of ranitidine and cimetidine on the pharmacokinetics and pharmacodynamics of warfarin in man. European Journal of Clinical Pharmacology 32: 165\u2013172, 1987","journal-title":"European Journal of Clinical Pharmacology"},{"key":"BF03259895_CR187","first-page":"834","volume":"115","author":"TK Truong","year":"1986","unstructured":"Truong TK, Grand\u2019Maison F, Longpr\u00e9 B. Myelotoxicose due \u00e0 la cim\u00e9tidine. Union M\u00e9dicale du Canada 115: 834\u2013836, 1986","journal-title":"Union M\u00e9dicale du Canada"},{"key":"BF03259895_CR188","first-page":"303","volume":"149","author":"G Tyden","year":"1983","unstructured":"Tyden G, Thulin L, Nyberg B. The effect of cimetidine on liver blood flow in anaesthetized man. Acta Chirurgica Scandinavica 149: 303\u2013305, 1983","journal-title":"Acta Chirurgica Scandinavica"},{"key":"BF03259895_CR189","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/S0016-5085(19)32167-5","volume":"73","author":"MH Ufberg","year":"1977","unstructured":"Ufberg MH, Brooks CM, Bosanac PR, Kintzel JE. Transient neutropenia in a patient receiving cimetidine. Gastroenterology 73: 635\u2013638, 1977","journal-title":"Gastroenterology"},{"key":"BF03259895_CR190","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1097\/00005373-197802000-00016","volume":"18","author":"P Valente","year":"1978","unstructured":"Valente P, Axelrod JL. Acute leukopenia associated with silver sulfadiazine therapy. Journal of Trauma 18: 146\u2013147, 1978","journal-title":"Journal of Trauma"},{"key":"BF03259895_CR191","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1111\/j.1365-2141.1984.tb02925.x","volume":"57","author":"DS Verma","year":"1984","unstructured":"Verma DS, Johnston DA, McCredie KB. Identification of T lymphocyte subpopulations that regulate elaboration of granulocyte-macrophage colony stimulating factor. British Journal of Haematology 57: 505\u2013520, 1984","journal-title":"British Journal of Haematology"},{"key":"BF03259895_CR192","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1007\/BF01972356","volume":"15","author":"MR Vickers","year":"1984","unstructured":"Vickers MR, Milliner KJ, Fallowfield C, Dracott BN. The effects of histamine H2-receptor antagonists on PHA induced lymphocyte proliferation. Agents and Actions 15: 242\u2013248, 1984","journal-title":"Agents and Actions"},{"key":"BF03259895_CR193","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1002\/hep.1840030606","volume":"3","author":"JP Villeneuve","year":"1983","unstructured":"Villeneuve JP, Fortunet-Fouin H, Ars\u00e8ne D. Cimetidine kinetics and dynamics in patients with severe liver disease. Hepatology 3: 923\u2013927, 1983","journal-title":"Hepatology"},{"key":"BF03259895_CR194","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1001\/archinte.1982.00340230221042","volume":"142","author":"RL Volkin","year":"1982","unstructured":"Volkin RL, Shadduck RK, Winkelstein A, Zeigler ZR, Selker R. Alternative mechanisms for severe neutropenia. Archives of Internal Medicine 142: 1971, 1982","journal-title":"Archives of Internal Medicine"},{"key":"BF03259895_CR195","doi-asserted-by":"crossref","first-page":"993","DOI":"10.7326\/0003-4819-90-6-993_1","volume":"90","author":"BA Wallin","year":"1979","unstructured":"Wallin BA, Jacknowitz A, Raich PC. Cimetidine and effect of warfarin. Annals of Internal Medicine 90: 993, 1979","journal-title":"Annals of Internal Medicine"},{"key":"BF03259895_CR196","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1055\/s-2008-1070914","volume":"105","author":"M Wehr","year":"1980","unstructured":"Wehr M, Sch\u00e4fer K, Bode JC. Granulozytopenie unter Cimetidintherapie. Deutsche Medizinische Wochenschrift 105: 1571\u20131573, 1980","journal-title":"Deutsche Medizinische Wochenschrift"},{"key":"BF03259895_CR197","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1016\/0006-2952(74)90227-5","volume":"23","author":"CF Wilkinson","year":"1974","unstructured":"Wilkinson CF, Hetnarski K, Cantwell GP, Di Carlo FJ. Structure-activity relationships in the effects of 1-alkylimidazoles on microsomal oxidation in vitro and in vivo. Biochemical Pharmacology 23: 2377\u20132386, 1974","journal-title":"Biochemical Pharmacology"},{"key":"BF03259895_CR198","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/0090-3019(85)90338-6","volume":"23","author":"YY Wong","year":"1985","unstructured":"Wong YY, Lichtor T, Brown FD. Severe thrombocytopenia associated with phenytoin and cimetidine therapy. Surgical Neurology 23: 169\u2013172, 1985","journal-title":"Surgical Neurology"},{"key":"BF03259895_CR199","first-page":"100","volume":"28","author":"E Yao","year":"1987","unstructured":"Yao E, Tsukasaki K, Kamei T, Kuriyama K, Ichimaru M. Effect of bolus methylprednisolone therapy on a case of cimetidine-associated aplastic anemia (in Japanese). Rinsho Ketsueki 28: 100\u2013105, 1987","journal-title":"Rinsho Ketsueki"},{"key":"BF03259895_CR200","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1136\/bmj.280.6229.1453-a","volume":"280","author":"VM Yates","year":"1980","unstructured":"Yates VM, Kerr REI. Cimetidine and thrombocytopenia. British Medical Journal 280: 1453, 1980","journal-title":"British Medical Journal"},{"key":"BF03259895_CR201","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1136\/bmj.285.6337.264","volume":"285","author":"ND Yeomans","year":"1982","unstructured":"Yeomans ND, Hanson RG, Smallwood RA, Mihaly GW, Louis WJ. Effect of chronic ranitidine treatment on secretion of intrinsic factor. British Medical Journal 285: 264, 1982","journal-title":"British Medical Journal"},{"key":"BF03259895_CR202","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1227\/00006123-198706000-00025","volume":"20","author":"CP Yue","year":"1987","unstructured":"Yue CP, Mann KS, Chan KH. Severe thrombocytopenia due to combined cimetidine and phenytoin therapy. Neurosurgery 20: 963\u2013965, 1987","journal-title":"Neurosurgery"},{"key":"BF03259895_CR203","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1056\/NEJM198312013092206","volume":"309","author":"JB Zeldis","year":"1983","unstructured":"Zeldis JB, Friedman LS, Isselbacher KJ. Ranitidine: a new H2-receptor antagonist. New England Journal of Medicine 309: 1368\u20131373, 1983","journal-title":"New England Journal of Medicine"},{"key":"BF03259895_CR204","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1056\/NEJM198501313120501","volume":"312","author":"NC Zoumbos","year":"1985","unstructured":"Zoumbos NC, Gascon P, Djeu JY, Trost SR, Young NS. Circulating activated suppressor T lymphocytes in aplastic anemia. New England Journal of Medicine 312: 257\u2013265, 1985","journal-title":"New England Journal of Medicine"},{"key":"BF03259895_CR205","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/S0140-6736(78)91665-3","volume":"2","author":"P Zulli","year":"1978","unstructured":"Zulli P, Di Nisio Q. Cimetidine treatment during pregnancy. Lancet 2: 945\u2013946, 1978","journal-title":"Lancet"}],"container-title":["Medical Toxicology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03259895.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF03259895\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03259895","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T22:57:16Z","timestamp":1745362636000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF03259895"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1988,12]]},"references-count":205,"journal-issue":{"issue":"6","published-print":{"date-parts":[[1988,12]]}},"alternative-id":["BF03259895"],"URL":"https:\/\/doi.org\/10.1007\/bf03259895","relation":{},"ISSN":["0112-5966"],"issn-type":[{"type":"print","value":"0112-5966"}],"subject":[],"published":{"date-parts":[[1988,12]]}}}